HEM Pharma Inc. (KOSDAQ:376270)

South Korea flag South Korea · Delayed Price · Currency is KRW
39,300
-750 (-1.87%)
At close: Jul 20, 2026
Market Cap282.02B +103.9%
Revenue (ttm)14.41B -9.9%
Net Income-25.61B
EPS-3,613.52
Shares Out 7.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,583
Open41,000
Previous Close40,050
Day's Range38,900 - 42,650
52-Week Range18,000 - 97,500
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376270
Full Company Profile

Financial Performance

Financial Statements